Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Vita Life Sciences Limited ( (AU:VLS) ).
Vita Life Sciences Limited has announced an update on its ongoing share buy-back program. The company reported the buy-back of 68,356 ordinary fully paid securities on the previous day, adding to a total of 289,032 securities bought back prior. This move is part of their strategy to manage capital efficiently, potentially improving shareholder value and market positioning.
The most recent analyst rating on (AU:VLS) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on Vita Life Sciences Limited stock, see the AU:VLS Stock Forecast page.
More about Vita Life Sciences Limited
Vita Life Sciences Limited operates in the health and wellness industry, focusing on providing a range of health supplements and pharmaceuticals. The company is known for its commitment to enhancing the well-being of its customers through innovative and scientifically-backed products.
Average Trading Volume: 11,518
Technical Sentiment Signal: Buy
Current Market Cap: A$139.6M
For a thorough assessment of VLS stock, go to TipRanks’ Stock Analysis page.